Vimarsana
Biggest News Aggregation in the World

Marissa Messinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marissa Messinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marissa Messinger Today - Breaking & Trending Today

An abortion at six months brings sorrow and redemption - Vimarsana News

An abortion at six months brings sorrow and redemption

Michelle Mitchenor's fetus had fatal defects. Her journey to an abortion reflects on America's conservative slide that has further stigmatized reproductive choices.

Why the first over-the-counter birth control pill is a hollow victory - Vimarsana News

Why the first over-the-counter birth control pill is a hollow victory

The progesterone-based 'minipill' Opill is, like all contraception, fallible. We don't have an answer to that after the Supreme Court's abortion reversal.

Editorial: The post-Roe strategy is to elect more abortion access champions - Vimarsana News

Editorial: The post-Roe strategy is to elect more abortion access champions

When the Supreme Court overturned this ruling last year, it sent the issue of reproductive rights to the states, where the fight over access has been waged ever since -- and will continue into coming years.

Oregon stockpiles supply of abortion pills - Los Angeles Times - Vimarsana News

Oregon stockpiles supply of abortion pills - Los Angeles Times

Oregon Gov. Tina Kotek says she has directed the state to bolster its supply of mifepristone, the most commonly used abortion medication in the U.S.

Editorial: The only thing certain about medication abortion is the confusion over how to get it - Vimarsana News

Editorial: The only thing certain about medication abortion is the confusion over how to get it

A federal appeals court has ruled that mifepristone, one of two drugs used in medication abortion, can remain on the market as a court case over whether it was properly approved by the FDA continues.